Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
12 angezeigte Treffer · Seite 4, keine Gesamtzahl für „Yuvanci“
Suchtreffer
Begriffe & Kennungen
Yuvanci · 4.8 · Liver aminotransferases In the double-blind period of the A DUE study with Yuvanci in patients with PAH the in
Eintrag öffnenYuvanci · 4.8 · Oedema/fluid retention
Eintrag öffnenYuvanci · 4.8 · Oedema/fluid retention has been associated with the use of ERAs including macitentan. In the double- blind per
Eintrag öffnenYuvanci · 4.8 · Platelets In the double-blind period of the A DUE study with Yuvanci in patients with PAH, the mean decrease f
Eintrag öffnenYuvanci · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenYuvanci · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenYuvanci · 4.8 · Summary of the safety profile
Eintrag öffnenYuvanci · 4.8 · Table 1: Adverse reactions in patients with PAH treated with Yuvanci, macitentan and/or tadalafil System organ
Eintrag öffnenYuvanci · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenYuvanci · 4.8 · The most common adverse reactions (occurring in the Yuvanci treated patients) from the combined double-blind /
Eintrag öffnenYuvanci · 4.8 · The safety data for Yuvanci was obtained from a double-blind, active controlled, Phase 3 clinical study (A DUE
Eintrag öffnenYuvanci · 4.8 · White blood cells In the double-blind period of the A DUE study with Yuvanci in patients with PAH, the mean de
Eintrag öffnen